Ho-Ryun Chung
Overview
Explore the profile of Ho-Ryun Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1774
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Czech T, Nelson P, Tholken C, Meyer P, Hess T, Chung H, et al.
HardwareX
. 2025 Jan;
18:e00517.
PMID: 39886005
The advent of single cell technologies resulted in growing demand for microfluidics in the biological sciences. Commercial platforms have remained expensive, inflexible, and non-customizable black boxes. We developed an open...
2.
Zein L, Grossmann J, Swoboda H, Borgel C, Wilke B, Awe S, et al.
Front Immunol
. 2024 Oct;
15:1401527.
PMID: 39416789
It has remained yet unclear which soluble factors regulate the anti-inflammatory macrophage phenotype observed in both homeostasis and tumourigenesis. We show here that haptoglobin, a major serum protein with elusive...
3.
Gao Y, Zandieh K, Zhao K, Khizanishvili N, Di Fazio P, Yu X, et al.
Cell Oncol (Dordr)
. 2024 Oct;
PMID: 39412616
Purpose: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers and several studies demonstrate that STAT3 has critical roles throughout the course of PDAC pathogenesis. Methods: TCGA, microarray,...
4.
Brichkina A, Ems M, Suezov R, Singh R, Lutz V, Picard F, et al.
Gut
. 2024 Jun;
73(10):1684-1701.
PMID: 38834297
Objective: Highly malignant pancreatic ductal adenocarcinoma (PDAC) is characterised by an abundant immunosuppressive and fibrotic tumour microenvironment (TME). Future therapeutic attempts will therefore demand the targeting of tumours and stromal...
5.
Race A, Fuchs A, Chung H
Sci Rep
. 2023 Dec;
13(1):22020.
PMID: 38086827
Chromosome conformation capture (3C) sequencing approaches, like Hi-C or micro-C, allow for an unbiased view of chromatin interactions. Most analysis methods rely on so-called interaction matrices, which are derived from...
6.
Maji R, Czepukojc B, Scherer M, Tierling S, Cadenas C, Gianmoena K, et al.
Epigenetics Chromatin
. 2023 Jul;
16(1):30.
PMID: 37415213
Fatty liver disease or the accumulation of fat in the liver, has been reported to affect the global population. This comes with an increased risk for the development of fibrosis,...
7.
Picard F, Lutz V, Brichkina A, Neuhaus F, Ruckenbrod T, Hupfer A, et al.
Gut
. 2023 Feb;
72(8):1510-1522.
PMID: 36759154
Objective: Pancreatic ductal adenocarcinoma (PDAC) is characterised by an abundant desmoplastic stroma composed of cancer-associated fibroblasts (CAF) and interspersed immune cells. A non-canonical CD8 T-cell subpopulation producing IL-17A (Tc17) promotes...
8.
Lutz V, Hellmund V, Picard F, Raifer H, Ruckenbrod T, Klein M, et al.
Cancer Immunol Res
. 2023 Feb;
11(4):421-434.
PMID: 36758176
Intratumoral cytotoxic CD8+ T cells (CTL) enter a dysfunctional state characterized by expression of coinhibitory receptors, loss of effector function, and changes in the transcriptional landscape. Even though several regulators...
9.
Stark M, Nicolai M, Tatura M, Keber C, Kaufmann A, Chung H, et al.
Cancer Med
. 2023 Jan;
12(7):8542-8556.
PMID: 36602302
Background: Toll-like receptors (TLRs) are gaining attention for their potential to influence tumor biology both on the level of the tumor cells as well as on the level of the...
10.
Fragkou P, Moschopoulos C, Dimopoulou D, Ong D, Dimopoulou K, Nelson P, et al.
Clin Microbiol Infect
. 2022 Nov;
29(3):291-301.
PMID: 36336237
Background: Molecular and antigen point-of-care tests (POCTs) have augmented our ability to rapidly identify and manage SARS-CoV-2 infection. However, their clinical performance varies among individual studies. Objectives: The evaluation of...